Aug 10, 2022 / 08:00PM GMT
Elizabeth Cristina Mari Garcia - UBS Investment Bank, Research Division - US Life Science Analyst
All right. Back for yet another session. All right. You got me again, Liza Garcia, UBS life science tools and diagnostics analyst. And we are super fortunate today. We have quite the team from Exact Sciences. We have got Jeff Elliott, the Chief Financial Officer; we have Jorge Garces, the Chief Science Officer; and we have Brian Baranick, the General Manager, Precision Oncology, with us today. So we would love to get started and hopefully walk through a couple of questions. All right. Welcome, guys.
Questions and Answers:
Elizabeth Cristina Mari Garcia - UBS Investment Bank, Research Division - US Life Science AnalystSo given that this is kind of the genomics conference, let's start with Thrive and the early detection cancer assay. It would be great to get an update from one of you on how the team is progressing there. I know there was data presented at AACR, and then there's a plan to share some kind of exciting data at ESMO, where we'll get to see the